Hormone levels during dietary changes in premenopausal African-American women

Journal of the National Cancer Institute

Volumn 88, Issue 19, 1996, Pages 1369-1374

  Woods, Margo N ^a   Barnett, Junaidah B ^a   Spiegelman, Donna ^b   Trail, Nancy ^a   Hertzmark, Ellen ^b   Longcope, Christopher ^c   Gorbach, Sherwood L ^a  

^a TUFTS UNIVERSITY SCHOOL OF MEDICINE   (United States)

^b HARVARD SCHOOL OF PUBLIC HEALTH   (United States)

^c UNIVERSITY OF MASSACHUSETTS MEDICAL SCHOOL   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

ANDROSTENEDIONE; ESTRADIOL; ESTROGEN; ESTRONE SULFATE; SEX HORMONE BINDING GLOBULIN;

ADULT; ARTICLE; BREAST CANCER; CAUCASIAN; CLINICAL ARTICLE; CONTROLLED STUDY; ESTROGEN BLOOD LEVEL; FEMALE; HIGH FIBER DIET; HUMAN; LOW FAT DIET; NEGRO;

EID: 0029762816     PISSN: 00278874     EISSN: None     Source Type: Journal    
DOI: 10.1093/jnci/88.19.1369     Document Type: Article

References (43)

1. Kosary CL, Ries LA, Miller BA, Hankey BF, Harras A, Edwards BK. SEER Cancer Statistics Review, 1973-1992. Bethesda (MD): National Cancer Institute; 1996 Report No.: DHHS Publ No. (NIH)96-2789.
2. Caplan LS, Helzlsouer KJ, Shapiro S, Freedman LS, Coates RJ, Edwards BK. System delay in breast cancer in whites and blacks. Am J Epidemiol 1995;142:804-12.
3. Coates RJ, Bransfield DD, Wesley M, Hankey B, Eley JW, Greenberg RS, et al. Differences between black and white women with breast cancer in time from symptom recognition to medical consultation. Black/White Cancer Survival Study Group. J Natl Cancer Inst 1992;84:938-50.
4. Bain RP, Greenber RS, Whitaker JP. Racial differences in survival of women with breast cancer. J Chronic Dis 1986;39:631-42.
5. McWhorter WP, Mayer WJ. Black/white differences in type of initial breast cancer treatment and implications for survival. Am J Public Health 1987;77:1515-7.
6. Kimmick G, Muss HB, Case LD, Stanley V. A comparison of treatment outcomes for black patients and white patients with metastatic breast cancer. The Piedmont Oncology Association experience. Cancer 1991;67:2850-4.
7. Eley JW, Hill HA, Chen VW, Austin DF, Wesley MN, Muss HB, et al. Racial differences in survival from breast cancer. Results of the National Cancer Institute Black/White Cancer Survival Study [see comment citation in Medline]. JAMA 1994;272:947-54.
8. National Health Survey Series. Hematological and nutritional biochemistry reference data for persons 6 month - 74 years of age: U.S., 1976-80:119. Washington (DC): US Dept Health and Human Services, Series 11, No. 232. 1982.
9. National Center for Health Statistics. Third National Health and Nutrition Examination Survey, Phase I, 1988-1991. No. 225. Hyattsville (MD): National Center for Health Statistics, October 24, 1994: 10.
10. Henderson BE, Ross R, Bernstein L. Estrogens as a cause of human cancer: the Richard and Hinda Rosenthal Foundation award lecture. Cancer Res 1988;48:246-53.
11. Key TJ, Pike MC. The role of oestrogens and progestagens in the epidemiology and prevention of breast cancer. Eur J Cancer Clin Oncol 1988;24:29-43.
12. Toniolo PG, Levitz M, Zeleniuch-Jacquotte A, Banerjee S, Koenig KL, Shore RE, et al. A prospective study of endogenous estrogens and breast cancer in postmenopausal women [see comment citation in Medline]. J Natl Cancer Inst 1995;87:190-7.
13. Begg L, Kuller LH, Gutai JP, Caggiula AG, Wolmark N, Watson CG. Endogenous sex hormone levels and breast cancer risk. Genet Epidemiol 1987;4:233-47.
14. Henderson BE, Gerkins V, Rosario I, Casagrande J, Pike MC. Elevated serum levels of estrogen and prolactin in daughters of patients with breast cancer. N Engl J Med 1975;293:790-5.
15. Pike MC, Casagrande JT, Brown JB, Gerkins V, Henderson BE. Comparison of urinary and plasma hormone levels in daughters of breast cancer patients and controls. J Natl Cancer Inst 1977;59:1351-5.
16. Prentice RL, Kakar F, Hursting S, Sheppard L, Klein R, Kushi LH. Aspects of the rationale for the Women's Health Trial. J Natl Cancer Inst 1988;80:802-14.
17. Armstrong BK, Brown JB, Clarke HT, Crooke DK, Hahnel R, Masarei JR, et al. Diet and reproductive hormones: a study of vegetarian and nonvegetarian postmenopausal women. J Natl Cancer Inst 1981;67:761-7.
18. Shultz TD, Leklem JE. Nutrient intake and hormonal status of premenopausal vegetarian Seventh-day Adventists and premenopausal nonvegetarians. Nutr Cancer 1983;4:247-59.
19. Goldin BR, Adlercreutz H, Gorbach SL, Warram JH, Dwyer JT, Swenson L, et al. Estrogen excretion patterns and plasma levels in vegetarian and omnivorous women. N Engl J Med 1982;307:1542-7.
20. Rose DP, Boyar AP, Cohen C, Strong LE. Effect of a low-fat diet on hormone levels in women with cystic breast disease. I. Serum steroids and gonadotropins. J Natl Cancer Inst 1987;78:623-6.
21. Prentice R, Thompson D, Clifford C, Gorbach S, Goldin B, Byar D. Dietary fat reduction and plasma estradiol concentration in healthy postmenopausal women. The Women's Health Trial Study Group. J Natl Cancer Inst 1990;82:129-34.
22. Jones LA, DiPaolo D, Insull W, David C, Johnston D, Mitchell MF, et al. The effect of low-fat diet on bioavailable estrogen levels in an ethnically diverse population [abstract]. Proc Am Assoc Cancer Res 1995;36:686.
23. Woods MN, Gorbach SL, Longcope C, Goldin BR, Dwyer JT, Morrill-LaBrode A. Low-fat, high-fiber diet and serum estrone sulfate in premenopausal women. Am J Clin Nutr 1989;49:1179-83.
24. Goldin BR, Woods MN, Spiegelman DL, Longcope C, Morrill-LaBrode A, Dwyer JT, et al. The effect of dietary fat and fiber on serum estrogen concentrations in premenopausal women under controlled dietary conditions. Cancer 1994;74(3 Suppl):1125-31.
25. Heber D, Ashley JM, Leaf DA, Barnard RJ. Reduction of serum estradiol in postmenopausal women given free access to low-fat high-carbohydrate diet. Nutrition 1991;7:137-9; discussion 139-40.
26. Rose DP, Goldman M, Connolly JM, Strong LE. High-fiber diet reduces serum estrogen concentrations in premenopausal women. Am J Clin Nutr 1991;54:520-5.
27. Gorbach SL, Morrill-LaBrode A, Woods MN, Dwyer JT, Selles WD, Henderson M, et al. Changes in food patterns during a low-fat dietary intervention in women. J Am Diet Assoc 1990;90:802-9.
28. Lee HP, Gourley L, Duffy SW, Esteve J, Lee J, Day NE. Risk factors for breast cancer by age and menopausal status: a case-report study in Singapore. Cancer Causes Control 1992;3:313-22.
29. Abraham GE, Hopper A, Tulchinsky D, Swerdloff RS, Odell WD, et al. Simultaneous measurements of plasma progesterone, 17-hydroxyprogesterol and estradiol-17β by radioimmunoassay. Anal Lett 1971;4:325-33.
30. Longcope C, Franz C, Morello C, Baker R, Johnston CC Jr. Steroid and gonadotropin levels in women during the peri-menopausal years. Maturitas 1986;8:189-96.
31. MacMahon W, Stallings J, Sgoutas D. A simple ultrafiltration method for determining unbound estradiol in serum. Clin Biochem 1983;16:240-3.
32. Mickelson KE, Petra PH. A filter assay for the sex steroid binding protein (SBP) of human serum. FEBS Lett 1974;44:34-8.
33. Morrison DF. Multivariate statistical methods. New York: McGraw-Hill, 1976.
34. Hankinson SE, Manson JE, Spiegelman D, Willett WC, Longcope C, Speizer FE. Reproducibility of plasma hormone levels in postmenopausal women over a 2-3-year period. Cancer Epidemiol Biomarkers Prev 1995; 4:649-54.
35. Potischman N, Falk RT, Laiming VA, Siiteri PK, Hoover RN. Reproducibility of laboratory assays for steroid hormones and sex hormone-binding globulin. Cancer Res 1994;54:5363-7.
36. Goldin BR, Gorbach SL. Hormone studies and the diet and breast cancer connection. In: Diet and breast cancer. New York: Plenum Press, 1994:35-46.
37. Ballard-Barbash R, Schatzkin A, Carter CL, Kannel WB, Kreger BE, D'Agostino RB, et al. Body fat distribution and breast cancer in the Framingham Study [see comment citation in Medline]. J Nail Cancer Inst 1990;82:286-90.
38. Folsom AR, Kaye SA, Prineas RJ, Potter JD, Gapstur SM, Wallace RB. Increased incidence of carcinoma of the breast associated with abdominal adiposity in postmenopausal women. Am J Epidemiol 1990;131:794-803.
39. Bruning PF. Endogenous estrogens and breast cancer a possible relationship between body fat distribution and estrogen availability. J Steroid Biochem 1987;27:487-92.
40. Sellers TA, Kushi LH, Potter JD, Kaye SA, Nelson CL, McGovern PG, et al. Effect of family history, body-fat distribution, and reproductive factors on the risk of postmenopausal breast cancer [published erratum appears in N Engl J Med 1992;327:1612] [see comment citation in Medline]. N Engl J Med 1992;326:1323-9.
41. Kirschner MA, Samojlik E, Drejka M, Szmal E, Schneider G, Ertel N. Androgen-estrogen metabolism in women with upper body versus lower body obesity. J Clin Endocrinol Metab 1990;70:473-9.
42. Evans DJ, Hoffmann RG, Kalkhoff RK, Kissebah AH. Relationship of androgenic activity to body fat topography, fat cell morphology, and metabolic aberrations in premenopausal women. J Clin Endocrinol Metab 1983;57:304-10.
43. Killinger DW, Perel E, Daniilescu D, Kharlip L, Lindsay WR. The relationship between aromatase activity and body fat distribution. Steroids 1987;50:61-72.